Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims
mcleanap2022-10-28T18:07:44-04:00Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), reports that its US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”), is dedicating additional resources to its SARS-CoV-2 protease inhibitor program.